Author

Hiroki Nakanishi

Primary ORCID profile (0000-0002-5108-1598 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Hiroki NakanishiiD2 papers

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Gen YoshiiiD· 1 shared Kentaro TomiiiD· 1 shared Maria SakuraiiD· 1 shared Matthew Jefferson· 1 shared Shoichi SuenagaiD· 1 shared Takeshi IwatsuboiD· 1 shared Thomas E. WilemaniD· 1 shared Tomoki KuwaharaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Gen YoshiiORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PIKfyve inhibition induces LRRK2 activation through phosphatidylinositol 3-phosphate and CASM

Tomoki Kuwahara, Gen Yoshii, Maria Sakurai, Shoichi Suenaga, Hiroki Nakanishi, Matthew Jefferson, Thomas E. Wileman, Kentaro Tomii, Takeshi Iwatsubo

This study shows that PIKfyve inhibition leads to LRRK2 hyperactivation through PI3P and CASM, revealing a new mechanism involving membrane lipids and Rab proteins.

bioRxiv · Dec 18, 2025 · PreprintCell Biology